These results, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the idea of focusing on ACKR3 as a novel method to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. It may also be https://alicek504qvy6.blogmazing.com/profile